Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics
Y Jin, M Liu, R Sa, H Fu, L Cheng, L Chen - Cancer Letters, 2020 - Elsevier
Due to a global increase in the incidence of thyroid cancer, numerous novel mouse models
were established to reveal thyroid cancer pathogenesis and test promising therapeutic …
were established to reveal thyroid cancer pathogenesis and test promising therapeutic …
Role of vandetanib in the management of medullary thyroid cancer
M Brassard, G Rondeau - Biologics: Targets and Therapy, 2012 - Taylor & Francis
Traditionally available treatments, like cytotoxic chemotherapy and external-beam radiation
therapy, are limited and essentially ineffective for metastatic medullary thyroid carcinoma …
therapy, are limited and essentially ineffective for metastatic medullary thyroid carcinoma …
Predictive value of 18F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib
Therapeutic options in advanced medullary thyroid carcinoma (MTC) have markedly
improved since the introduction of tyrosine kinase inhibitors (TKIs). We aimed to assess the …
improved since the introduction of tyrosine kinase inhibitors (TKIs). We aimed to assess the …
[HTML][HTML] Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti-angiogenic effects in zebrafish model
S Carra, G Gaudenzi, A Dicitore, D Saronni… - International Journal of …, 2021 - mdpi.com
Medullary thyroid carcinoma (MTC) is a tumor deriving from the thyroid C cells. Vandetanib
(VAN) and cabozantinib (CAB) are two tyrosine kinase inhibitors targeting REarranged …
(VAN) and cabozantinib (CAB) are two tyrosine kinase inhibitors targeting REarranged …
Evaluation of the Genisys4, a bench-top preclinical PET scanner
The Genisys4 is a small bench-top preclinical PET scanner designed to enable imaging in
biology, biochemistry, and pharmacology laboratories and imaging centers. Here, we …
biology, biochemistry, and pharmacology laboratories and imaging centers. Here, we …
[HTML][HTML] Volumetric and texture analysis of pretherapeutic 18F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib
Purpose The metabolically most active lesion in 2-deoxy-2-(18 F) fluoro-D-glucose (18 F-
FDG) PET/CT can predict progression-free survival (PFS) in patients with medullary thyroid …
FDG) PET/CT can predict progression-free survival (PFS) in patients with medullary thyroid …
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
M Tiseo, M Ippolito, M Scarlattei, P Spadaro… - Cancer chemotherapy …, 2014 - Springer
Abstract Background [18F] fluorodeoxyglucose (FDG)-PET is being evaluated as a tool for
the early detection of response to various targeted agents in solid tumors. The aim of this …
the early detection of response to various targeted agents in solid tumors. The aim of this …
[PDF][PDF] Vandetanib therapy in medullary thyroid cancer
SUMMARY The US Food and Drug Administration (FDA) approved vandetanib in April 2011
for the treatment of unresectable, locally advanced or metastatic medullary thyroid cancer …
for the treatment of unresectable, locally advanced or metastatic medullary thyroid cancer …
[HTML][HTML] The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CT
S Basu - Discovery Medicine, 2012 - discoverymedicine.com
Behavioral heterogeneity within a given patient cohort has been a major challenge in
clinical practice and is probably most prominently observed in the field of oncology. This has …
clinical practice and is probably most prominently observed in the field of oncology. This has …
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma
S De Luca, R Fonti, L Camera, B Salvatore… - Annals of nuclear …, 2016 - Springer
Objective The aim of our study was to determine the role of fluorine-18 fluorodeoxyglucose
positron emission tomography/computed tomography (18 F-FDG-PET/CT) and indium-111 …
positron emission tomography/computed tomography (18 F-FDG-PET/CT) and indium-111 …